Huawei banned from UK 5G network from 2021
The government has banned Chinese technology firm Huawei from providing telecommunications equipment to the UK’s mobile 5G network from the…
The government has banned Chinese technology firm Huawei from providing telecommunications equipment to the UK’s mobile 5G network from the…
By Alexander O'Leary It seems like for years the virtual clinical trial has been the future, and it is perhaps…
Applied artificial intelligence (AI) healthcare company Viz.ai has announced new algorithms and expanded features for its clinical trial platform, Viz RECRUIT. By employing AI, Viz…
OncoSec Medical has secured a multi-year ClinSite licence from clinical development analytics products and services provider Phesi. ClinSite is a self-service, artificial intelligence (AI)-powered tool…
Eidos Therapeutics starts Phase III trial of AG10 in ATTR-CM Eidos Therapeutics commenced a pivotal Phase III clinical trial of…
Janssen unblinds Phase III TITAN study for prostate cancer Janssen Pharmaceutical Companies of Johnson & Johnson unblinded the Phase III…
OpenClinica is pleased to announce that it will be included in public television series In Depth, exhibiting its clinical trials…
ORGOVYX™ (relugolix) is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of advanced prostate…
EVERSANA™ and Experic are pleased to announce that they will be partnering to aid life sciences companies in optimising clinical…
When you need customised and scalable filling, packaging and logistics solutions for reservoir and single-dose dry powder inhalation (DPI) devices,…